65,437 trials
Leukemia · Myelodysplastic Syndromes · Myelodysplastic/Myeloproliferative Neoplasms
Primary: Complete Response Rate — 35.3 percentage of participants
Prostate Cancer
Primary: Proportion of Patients Showing PSA Nadir — 83 percentage of patients with PSA nadir
Plaque Psoriasis
Primary: Percentage of Participants Achieving a Psoriasis Area and Severity Index Greater Than or Equal to 75% Reduction (PASI 75) Response at Week 12 — 11.5; 77.8 percentage of…
Healthy
Primary: Safety of Escalating Multiple Doses of N6022 in Healthy Subjects — 7; 6; 6; 6 participants
Myopia
Primary: Daily and Comfortable Wearing Time — 9.8; 7.7 hours
Sexual Dysfunction · Sexuality and Reproductive Issues · Unspecified Adult Solid Tumor, Protocol Specific
Primary: Sexual Function — 17.81; 17.15 units on a scale — p=0.576
Cataract
Primary: Photostress Recovery Time — 5.66; 6.94 seconds
Neoplasm
Primary: Maximum Tolerated Dose (MTD) — 100 mg
Head and Neck Cancer
Primary: Compliance With Treatment . — 74 percentage of participants
Papulopustular Rosacea (PPR)
Primary: Success Rate — 38.4; 11.6 Percentage of participants — p=<0.001
Stress Urinary Incontinence
Primary: Mean Percentage of Pad Weight Gain (PWG) Change — 90.8; 98.5; 99.3; 89.3 Mean percentage of PWG change
Dyskinesias · Parkinson's Disease · Severe Motor Fluctuations
Primary: Number of Participants With Adverse Events (AEs), Serious AEs (SAEs), Deaths and Discontinuations Due to AEs — 0; 0; 0; 0 participants
Complicated Intra-abdominal Infection
Primary: Clinical Response of CXA 101/Tazobactam and Metronidazole at Test of Cure (TOC) Visit in the Microbiological Modified Intent to Treat (mMITT) Analysis Population — 83.6…
Advanced Parkinson's Disease
Primary: Change From Baseline to Week 12 in Average Daily Normalized "Off" Time — -4.04; -2.14 hours — p=0.0015
Multiple Myeloma · Smoldering Multiple Myeloma · Monoclonal Gammopathy of Undetermined Significance
Primary: Count of Participants With Positive and Negative 18F-FDG PET CT and F18-NaF PET CT Imaging Results in Individuals With MGUS, SMM, and MM. — 0; 1; 5; 10 Participants